EP2926855
Nefúðatæki
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.10.2011EP published:
5.12.2018EP application number:
15164095.0
EP translation filed:
25.2.2019Grant published:
15.3.2019EPO information:
European Patent Register
Max expiry date:
11.10.2031Expiry date:
11.10.2025Next due date:
31.10.2025
Title:
NASAL SPRAY DEVICE
Timeline
Today
12.10.2011EP application
5.12.2018EP Publication
25.2.2019Translation submitted
15.3.2019Registration published
11.10.2025Expires
Owner
Name:
Ivax Pharmaceuticals IrelandAddress:
Unit 301 Industrial Park, Waterford, IE
Name:
Teva Branded Pharmaceutical Products R & D, Inc.Address:
425 Privet Rd, 19044, Horsham, PA, US
Inventor
Name:
Walsh, DeclanAddress:
Co.Kilkenny, IE
Name:
Zeng, Xian-MingAddress:
Miami, FL, US
Name:
Ly, JadeAddress:
Miami, FL, US
Name:
Morales, ArmandoAddress:
Miami, FL, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
392223 PDate:
12.10.2010Country:
US
Classification
Categories:
A61M 15/08
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 18.9.2019
Expires: 11.10.2020
Payer: Tego ehf.
Number: 10
Paid: 12.10.2020
Expires: 11.10.2021
Payer: G.H. Sigurgeirsson ehf.
Number: 11
Paid: 12.10.2021
Expires: 11.10.2022
Payer: G.H. Sigurgeirsson ehf.
Number: 12
Paid: 11.10.2022
Expires: 11.10.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 13
Paid: 6.10.2023
Expires: 11.10.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 23.9.2024
Expires: 11.10.2025
Payer: Árnason Faktor ehf.